A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2
Clinical trial NCT04221451 · TERMINATED
Trial details
- NCT number
- NCT04221451
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2024-12-26
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.